ATTAIN PERFORMA MRI SURESCAN
Report
- Report Number
- 2649622-2026-08456
- Event Type
- Injury
- Date Received
- March 26, 2026
- Date of Event
- January 21, 2024
- Report Date
- March 26, 2026
- Manufacturer
- MEDTRONIC PUERTO RICO VILLALBA
- Product Code
- OJX
- UDI-DI
- 00643169601826
- PMA / PMN Number
- P080006
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IL, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
H11: THIS REGULATORY REPORT IS BEING SUBMITTED AS PART OF A RETROSPECTIVE REVIEW AND REMEDIATION RELATED TO CAPA 711948. CONTINUATION OF D10: 350 973 LEAD IMPLANTED: (B)(6) 2013, 350 974 LEAD IMPLANTED: (B)(6) 2013, W4TR01 CRTP IMPLANTED: (B)(6) 2023, TYRX-AAE IMPLANTED: (B)(6) 2023 MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.
IT WAS REPORTED THAT APPROXIMATELY ONE MONTH POST IMPLANT OF A CARDIAC RESYNCHRONIZATION THERAPY PACEMAKER (CRT-P) SYSTEM WITH AN ANTIBACTERIAL ABSORBABLE ENVELOPE, THE PATIENT PRESENTED WITH AN INFECTION. THE CRTP SYSTEM WAS EXPLANTED AND REPLACED. NO FURTHER PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 760106 | ATTAIN PERFORMA MRI SURESCAN | DRUG ELUTING PERMANENT LEFT VENTRICULAR (LV) P | OJX | MEDTRONIC PUERTO RICO VILLALBA | 429878 | 00643169601826 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 78 YR | Male | Required Intervention| H | "SEE H11...." |